DISCO Pharmaceuticals GmbH

📍 Cologne, Germany🗓 Founded 2022👥 28 employees💰 Last funded Apr 2025
Pharmaceutical Manufacturing🌐 discopharma.de
Website LinkedIn
DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in DISCO Pharmaceuticals GmbH?
DISCO Pharmaceuticals GmbH has 1 investors on record on gritt.io, 1 mid-stage.
When did DISCO Pharmaceuticals GmbH last raise funding?
The most recent investment in DISCO Pharmaceuticals GmbH recorded on gritt.io was in April 2025.
When was DISCO Pharmaceuticals GmbH founded?
DISCO Pharmaceuticals GmbH was founded in 2022.
What industry is DISCO Pharmaceuticals GmbH in?
DISCO Pharmaceuticals GmbH operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is DISCO Pharmaceuticals GmbH based?
DISCO Pharmaceuticals GmbH is headquartered in Cologne, Germany.